Stroke-related deaths increased during the first lockdown

NewsGuard 100/100 Score

Deaths of people who suffered strokes increased during the first lockdown compared to the three previous years, new data analysis has found. Despite the pandemic, health care quality was maintained at a high level.

In their paper, published today in Stroke American Heart Association, research teams from King's College London, Guy's and St Thomas' NHS Foundation and the Sentinel Stroke National Audit Programme (SSNAP) analyzed the data of 184,017 patients admitted to hospital with confirmed stroke during October-April periods across four consecutive years. This patient data were collected from 114 hospital trusts in England, Wales and Northern Ireland.

Starting from the third week of February 2020 there was an increase in seven-day in-patient case fatality (people who died within seven days of being admitted to hospital) from 6.9% to 9.4%, compared to the same period in the three previous years.

This was significantly higher in stroke patients with confirmed or suspected COVID-19, at 22.0% and 21.9% respectively, compared to 7.3% for patients with negative/unknown COVID-19 status.

In contrast, during the first lockdown the number of people admitted to hospital with a stroke remained stable until the second week of February 2020 when there was a steep decline. Between 23 March and 30 April 2020 there was a 12% reduction in stroke admissions compared to the same period in the three previous years (6,923 versus 7,902).

The team found that during the first lockdown stroke admissions fell more for:

  • Ischemic stroke (blockage cutting off the blood supply to the brain) than hemorrhagic stroke (bleeding in or around the brain)
  • Older patients (aged over 65 years)
  • Patients with less severe strokes

No change was found in the proportion of patients discharged from hospital with good outcomes.

Quality of care was preserved for all measures and in some areas improved during lockdown, such as access to stroke unit care, speed of screening for dysphagia and access to rehabilitation therapies.

We know the immediate impact of the COVID-19 pandemic was to cause a reduction in the number of people presenting to hospital with stroke, an effect that was evident from early February and well before the imposition of population-level lockdown measures. This fall in admissions was predominantly for patients with mild symptoms and particularly in patients over the age of 85 years. Whether this was because there was a reluctance to refer patients to hospital due to their increased risk if they did contract coronavirus, in an attempt to reduce the burden on the health service or because the patients were not able to alert emergency services themselves or decided against referral is not known."

Dr Abdel Douiri, Study Lead from King's College London

Dr Douiri added: "Despite maintaining high quality services, the seven-day case fatality rate for stroke increased significantly by 2.5% percentage points. It is not possible to determine if this higher mortality is explained by the high case fatality rates in patients with confirmed or suspected COVID-19 or as a result of fewer patients with milder stroke being admitted to hospital, or a combination of these effects."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates